Blend Rationale: This combination is of interest for multi-pathway metabolic research involving bioenergetics, mitochondrial signaling, and nutrient-sensing systems
SOC 2 Type II
Important Safety Information Do not use AOD-9604 if you: Have a known hypersensitivity to growth hormone fragments or any component of the formulation Have active malignancy (cancer that is currently being treated or monitored) Are pregnant or breastfeeding (insufficient safety data) Have a history of severe allergic reactions to peptide therapies Common side effects (typically mild and transient): Headache, mild gastrointestinal disturbances (flatulence, mild diarrhea at higher doses), upper respiratory tract symptoms, injection site reactions (redness, mild discomfort) Seek medical attention if you experience: Signs of allergic reaction (hives, difficulty breathing, swelling of face or throat), persistent gastrointestinal symptoms, unexplained significant changes in energy, mood, or physical symptoms Clinical Safety Data Safety studies involving approximately 900 participants across six randomized controlled trials documented that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo across most parameters
it even helps you lose some
It demonstrated that the lipolytic activity of GH localizes to the C-terminal part and that a synthetic fragment can reproduce this activity without the other GH effects
Lipolysis Stimulation The peptide has been shown to stimulate lipolysis - the breakdown of triglycerides stored in adipocytes into free fatty acids and glycerol that can be released into circulation for use as energy by other tissues
